Autogenous Demineralized DentinNCT07777588
Clinical and Radiographic Assessment of Socket Preservation Using Autogenous Demineralized Dentin Matrix Versus Xenograft
A study testing Autogenous Demineralized Dentin and application of xenograft in people with Autogenous Demineralized Dentin and Xenograft Bone Graft, run by Delta University for Science and Technology at 1 site in Egypt.
Trial summary
Total of 40 participants were planned for enrollment for socket preservation, 20 in the Autogenous Demineralized Dentin group and 20 in the Xenograft group these materials used for socket preservation after extraction. Read more about this study
- Who is it for?
- Ages 18 to 50 yearsHealthy volunteers can take part
- Conditions the study is for
- Autogenous Demineralized Dentin, Xenograft Bone Graft
- What is being tested?
- Autogenous Demineralized Dentin and application of xenograft
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteEgypt
- Study dates
- 28 Jun 2025to 22 Apr 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 50 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Exclusion Criteria smokers , condition affecting bone metabolism
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Clinical and Radiographic Assessment of Socket Preservation Using Autogenous Demineralized Dentin Matrix Versus Xenograft: A Randomized Controlled Trial
Total of 40 participants were planned for enrollment for socket preservation, 20 in the Autogenous Demineralized Dentin group and 20 in the Xenograft group these materials used for socket preservation after extraction. Participants were assessed for changes in bucco-lingual width at different point, bone density and changes in bone volume, keratinized tissue width.
- Being tested
- Autogenous Demineralized Dentin, application of xenograft
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Autogenous Demineralized DentinProcedure or surgery
application of Autogenous Demineralized Dentin
application of xenograftProcedure or surgery
application of xenograftxenograft
| Study group | Role | What they receive |
|---|---|---|
| Autogenous Demineralized Dentin | Experimental | Not described Receives: Procedure: Autogenous Demineralized Dentin |
| Xenograft bone graft | Active comparator | Not described Receives: Procedure: application of xenograft |
What is being measured
The primary outcome is the main question the study is designed to answer.
bucco-lingual bone width
measuring width in mm at different points
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Aug 2026
- Study start28 Jun 2025
- Primary completion22 Apr 2026
- Study completion22 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Autogenous Demineralized DentinStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- Delta University for Science and Technology
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07777588
- Sponsor's protocol ID
- DU:125052221
- Status last verified
- Jun 2025
- First submitted
- 15 Aug 2026
- Last updated
- 20 Aug 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical and Radiographic Assessment of Socket Preservation Using Autogenous Demineralized Dentin Matrix Versus Xenograft: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07777588
- Acronym / sponsor ID
- DU:125052221
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- Delta University for Science and TechnologyUniversity, hospital or other
- Study start
- 28 Jun 2025 (actual)
- Primary completion
- 22 Apr 2026 (actual)
- Study completion
- 22 Apr 2026 (actual)
- First posted
- 20 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Total of 40 participants were planned for enrollment for socket preservation, 20 in the Autogenous Demineralized Dentin group and 20 in the Xenograft group these materials used for socket preservation after extraction. Participants were assessed for changes in bucco-lingual width at different point, bone density and changes in bone volume, keratinized tissue width.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Autogenous Demineralized Dentin | Experimental | Procedure: Autogenous Demineralized Dentin |
| Xenograft bone graft | Active comparator | Procedure: application of xenograft |
Who may qualify
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Exclusion Criteria smokers , condition affecting bone metabolism
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Autogenous Demineralized Dentinapplication of Autogenous Demineralized Dentin | Procedure or surgery | Autogenous Demineralized Dentin |
| application of xenograftapplication of xenograftxenograft | Procedure or surgery | Xenograft bone graft |
Primary outcome
bucco-lingual bone width
Time frame: 6 months
measuring width in mm at different points
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Aug 2026.
Related trials for Autogenous Demineralized Dentin
Not yet recruiting
Effect of Ascorbic Acid-Loaded I-PRF With Partially Demineralized Dentin Graft on Alveolar Ridge Preservation
Alveolar Ridge Preservation Post-Extraction Bone Healing Dental Implant Site Development Tooth Loss, Alveolar Bone Regeneration Following Odontectomy
Active, not recruiting
Bone Defects Reconstruction After Dentigerous Cyst Enucleation With Autogenous Demineralized Dentin Matrix- ADDM and Advanced Platelet-Rich Fibrin- A-PRF.
Impact Molar, Mandible Cyst
Recruiting
Evaluation of Dentin Graft and I-PRF With and Without Vitamin C for Post-extraction Socket Preservation
Socket Preservation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Autogenous Demineralized Dentin and application of xenograft in people with Autogenous Demineralized Dentin and Xenograft Bone Graft, run by Delta University for Science and Technology at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
bucco-lingual bone width (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.